NAVB   $0.0779  -2.99% Market Closed

Navidea Biopharmaceuticals Inc

EMA (20): 2023-07-24 the price crossed down the moving average line and demonstrates a downside trend.

EMA (50): 2023-04-17 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2023-03-23 the price crossed down the moving average line and demonstrates a downside trend.

RSI: RSI indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

Trend Type flat and down
Power None
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -28.27%
EMA (20) date of signal July 24, 2023, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -73.94%
EMA (50) date of signal April 17, 2023, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -76.21%
EMA (100) date of signal March 23, 2023, 3 a.m.
RSI Signals bullish reversal
RSI (14) Yield 0.0
RSI (14) date of signal Aug. 8, 2023, 3 a.m.
MACD Signals bearish
MACD Yield -24.41%
MACD date of signal July 28, 2023, 3 a.m.
Stochastic Signals bearish weakening
Stochastic Yield 0.0
Stochastic date of signal Aug. 8, 2023, 3 a.m.
Updated Aug. 9, 2023, 2:28 p.m.